tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Liisa Bayko, 138 are a BUY (87.9%), 18 are a HOLD (11.46%), 1 are a SELL (0.64%).
Analyst Liisa Bayko, carries an average stock price target met ratio of 46.34% that have a potential upside of 49.89% achieved within 273 days. Previously, Liisa Bayko worked at EVERCORE.
Liisa Bayko’s has documented 329 price targets and ratings displayed on 32 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on RARE, Ultragenyx at 18-Feb-2026.
Analyst best performing recommendations are on ENTA (ENANTA PHARMACEUTICALS).
The best stock recommendation documented was for ENTA (ENANTA PHARMACEUTICALS) at 9/15/2025. The price target of $12 was fulfilled within 14 days with a profit of $4.54 (60.86%) receiving and performance score of 43.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Sep-2020
$5
$0.47 (10.38%)
$5
3 months 22 days ago
(14-Nov-2025)
4/14 (28.57%)
$0.48 (10.62%)
136
Buy Since 28-Jun-2022
$5
11 months 5 days ago
(31-Mar-2025)
2/6 (33.33%)
$1.26 (33.69%)
256
Buy Since 08-Dec-2021
$5
$0.47 (10.38%)
$5
1 years 1 months 15 days ago
(21-Jan-2025)
0/17 (0%)
$1.79 (55.76%)
Buy Since 02-Feb-2022
$5
$0.47 (10.38%)
4 years 1 months 6 days ago
(02-Feb-2022)
0/1 (0%)
$2.11 (73.01%)
Buy Since 27-Jul-2020
$7
4 years 8 months 8 days ago
(28-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
Which stock is Liisa Bayko is most bullish on?
Which stock is Liisa Bayko is most reserved on?
What Year was the first public recommendation made by Liisa Bayko?
